Bunkerhill AVC vs Lung AI

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Bunkerhill AVC

by BunkerHill Health

Lung AI

by Exo

AI Verdict

Bunkerhill AVC and Lung AI are adjacent competitors, both utilizing AI for medical imaging analysis in cardiology and pulmonology, but with distinct approaches. Bunkerhill AVC focuses on analyzing existing CT scans for calcification detection and integrates with EHRs for workflow automation, while Lung AI is integrated into a handheld ultrasound device for real-time, point-of-care diagnostics of lung and cardiac conditions.

Choose Bunkerhill AVC if…

Choose Bunkerhill AVC if your health system regularly performs chest CTs and aims to opportunistically screen for aortic valve calcification (AVC) and other cardiovascular risks. This tool integrates with existing EHRs and clinical archives to automate the detection and quantification of AVC from both non-contrast and contrast-enhanced CT scans, enabling early identification of patients who may be at risk for aortic stenosis and facilitating proactive management.

View Bunkerhill AVC →

Choose Lung AI if…

Choose Lung AI if your clinical setting requires a portable, real-time diagnostic solution for lung and cardiac conditions at the point of care. Integrated with the Exo Iris handheld ultrasound device, this tool is ideal for emergency medicine, pulmonology, and cardiology specialists who need immediate AI-powered detection of pleural effusion, consolidation/atelectasis, and cardiac indicators like ejection fraction, even in resource-limited environments or for less experienced users.

View Lung AI →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Bunkerhill AVC	Lung AI
Pricing	Contact for pricing	Contact for pricing
Deployment	Integrates with full Electronic Health Records (EHRs) and clinical archives within health systems.	On-device (integrated with Exo Iris handheld ultrasound device)
BAA Available	Unknown	Yes AI-estimated
FDA Status	1 AI-estimated	1 AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Lung AI

Exo's Lung AI, integrated with the handheld Exo Iris ultrasound device, is designed for intuitive operation, even for clinicians with limited ultrasound experience. Its SweepAIu2122 technology provides real-time feedback and automatically identifies quality images, simplifying the image acquisition process. Bunkerhill AVC, while integrating with existing EHRs, is part of a broader platform for clinical reasoning and action, which may have a steeper learning curve for its full generative AI capabilities.

Clinical Value

Lung AI

Exo's Lung AI offers real-time, AI-powered detection of pleural effusion and consolidation/atelectasis directly on a handheld ultrasound device, enabling immediate critical decisions at the point of care. Studies show AI assistance significantly improved clinician accuracy in lung ultrasound interpretation, particularly benefiting less experienced users. While Bunkerhill AVC provides early detection and quantification of aortic valve calcification from CTs, its impact is more focused on identifying at-risk patients for follow-up rather than immediate diagnostic intervention.

Pricing & Value

Tie

Both tools require contacting the company for pricing, making a direct comparison difficult. However, both aim to provide value through improved patient outcomes and streamlined workflows. Exo's handheld device and on-device AI processing could offer cost savings by making advanced imaging more accessible and reducing the need for more expensive, cart-based systems. Bunkerhill Health has secured a CMS reimbursement pathway for its AI cardiovascular analysis, which could improve its value proposition for health systems.

Enterprise Readiness

Bunkerhill AVC

Bunkerhill AVC is part of the broader Carebricks platform, which integrates with full Electronic Health Records (EHRs) and clinical archives, enabling customizable AI agents for diverse workflows and automated care coordination. This deep integration and workflow automation suggest a higher level of enterprise readiness for system-wide deployment and impact. Exo's Lung AI, while FDA-cleared and integrated with its handheld device, focuses more on point-of-care diagnostics, which may have a different, less extensive integration footprint within a large enterprise.

Innovation

Bunkerhill AVC

Bunkerhill Health's Carebricks platform utilizes generative AI for clinical reasoning and action, allowing for customizable AI agents and natural language processing for patient record interaction (Carebricks Chat). This broader generative AI approach for automating workflows and clinical reasoning represents a significant innovative step beyond specific image analysis. Exo's on-device AI and real-time feedback are innovative for point-of-care ultrasound, but Bunkerhill's generative AI platform offers a more expansive and adaptable innovation in healthcare AI.

Support & Docs

Tie

Neither the provided structured facts nor the web search results offered specific details about the level of customer support or documentation available for either Bunkerhill AVC or Lung AI. Both companies are established in the healthcare AI space and would likely offer standard support, but without further information, a definitive winner cannot be determined.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Bunkerhill AVC	Lung AI
Name	Bunkerhill AVC	Lung AI
Company	BunkerHill Health	Exo
Tagline	Generative AI for clinical reasoning and action.	Handheld AI Ultrasound for Smarter Cardiac and and Lung Scanning.
Key Features (Cardiology/Radiology)	Automated detection and quantification of aortic valve calcification (Bunkerhill AVC), Automated detection and quantification of coronary artery calcification (iCAC, Contrast CAC), Automated detection and quantification of mitral annular calcification (Bunkerhill MAC), Opportunistic bone density assessment (Bunkerhill BMD)	Automated AI-based indicators for cardiac conditions (e.g., heart failure, hypertrophy)
Key Features (Pulmonology/Lung)	Not specified	AI-powered detection of pleural effusion, AI-powered detection of consolidation/atelectasis

Videos

Demos, reviews, and walkthroughs featuring Bunkerhill AVC and Lung AI.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How deeply does Bunkerhill AVC integrate into existing EHR and clinical workflows, and what is the typical time-to-value for a health system implementing it?

Bunkerhill AVC integrates with full EHRs and clinical archives to automate workflows. It processes routine chest CTs to identify elevated aortic valve calcification, alerts cardiology and primary clinicians, and can place follow-up orders or visits. The Carebricks platform, which includes Bunkerhill AVC, is designed to enable health systems to deploy AI agents for clinical and operational tasks in days, not months or years, suggesting a rapid time-to-value.

What is the reported accuracy and sensitivity of Bunkerhill AVC for detecting and quantifying aortic valve calcification?

Bunkerhill AVC detects, localizes, and quantifies aortic valve calcification in non-gated, non-contrast chest CT studies. In a pivotal study, it demonstrated a low mean difference of -5.15 AU compared to ground truth, with precision of 0.826 and recall of 0.855.

What is the learning curve for physicians using Exo Lung AI, especially for those with less ultrasound experience?

Exo Lung AI is designed to assist clinicians with varying expertise levels in interpreting lung ultrasound scans. Studies show that AI assistance significantly enhances the detection capabilities of clinicians, particularly benefiting less experienced users, with performance approaching expert levels. The system also includes SweepAI for real-time image quality feedback and Exo U for AI-powered POCUS education and training.

What are the key clinical contexts where Exo Lung AI provides the most significant benefit for patient care?

Exo Lung AI is particularly beneficial in point-of-care settings like emergency departments, enabling rapid detection of pleural effusion and consolidation/atelectasis. This can help clinicians quickly diagnose lung diseases such as pneumonia and tuberculosis, and differentiate between conditions like COPD and CHF, leading to faster treatment decisions and improved patient outcomes.

Beyond standard compliance, what specific security features or protocols does Bunkerhill Health implement to protect patient data within its Carebricks platform?

Bunkerhill Health's Carebricks platform integrates directly with EHRs and clinical archives. When chest CT scans are captured, images are automatically sent via DICOM protocol to an on-premises server, de-identified, and then sent to a cloud server for AI processing. The results are then re-identified and routed back to the physician's workflow.

Are there customer references or case studies available for multi-site rollouts of either Bunkerhill AVC or Exo Lung AI?

McLaren Health Care, in partnership with Bunkerhill Health, has launched an AI-powered cardiovascular screening program using Bunkerhill's AVC algorithm across its system, indicating successful multi-site implementation. Similar programs are also being performed at other health systems including Mayo Clinic, Cleveland Clinic, and West Virginia University Medicine.

What audit-trail features are available in both tools to track AI-driven insights and subsequent clinical actions?

Bunkerhill's Carebricks platform is designed to automate next steps, such as notifying care teams, generating documentation, or initiating referrals, which implies a system for tracking these actions. For Exo Lung AI, while not explicitly detailed, the AI provides objective data and real-time indicators, which would likely be part of a digital record within the Exo Iris device.